Analysts’ views on UnitedHealth Group
UnitedHealth Group (UNH) is one of the leading healthcare companies in the world, offering healthcare products and insurance services. It’s the fifth-largest Fortune 500 firm.
The company has posted steady stock price performance over the last year. However, the stock declined marginally over the last month on macroeconomic factors and competitive threats in the industry. In this article, let’s look at analysts’ recommendations for UNH stock.
Of the 23 analysts covering UNH stock on June 29, 11 gave “strong buy” recommendations. The other 12 analysts gave “buy” ratings for the company, as shown in the chart above.
According to these analysts, the consensus target price for UNH stock for the next 12 months is $279.14. This target price represents a return of ~12.6% on an investment in UNH stock for the next 12 months. This return is based on UNH’s closing price of $244.90.
Analysts’ average target prices for UNH peers Aetna (AET), Anthem (ANTM), and Cigna (CI) are $203.19, $283.47, and $218.28, respectively, implying 9.6%, 18.5%, and 28.6% returns over the next 12 months.
Recent ratings and target price updates
On June 21, BMO raised its target price on UNH stock from $285.00 to $300.00. On June 7, BMO increased its target price on UNH stock from $275.00 to $285.00. In April, multiple analysts had increased their target prices on UNH stock and made upward revisions to their stock recommendations based on the company’s strong first-quarter results.
Check out all the data we’ve added to our quote pages. Now you can get a valuation snapshot, earnings and revenue estimates, and historical data as well as dividend info. Take a look!